Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immu...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Rossi, Ernesto, Schinzari, Giovanni, Zizzari, Ilaria Grazia, Maiorano, Brigida Anna, Pagliara, Monica Maria, Sammarco, Maria Grazia, Fiorentino, Vincenzo, Petrone, Gianluigi, Cassano, Alessandra, Rindi, Guido, Bria, Emilio, Blasi, Maria Antonietta, Nuti, Marianna, Tortora, Giampaolo
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2019
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721347/
https://ncbi.nlm.nih.gov/pubmed/31357439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081055
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы